Uncategorised - European Medical Journal

Medicine in the Metaverse: An Interview with Shafi Ahmed

Shafi Ahmed, a world-renowned surgeon, futurist, innovator, professor, and Nobel Peace Prize nominee, shares exclusive insights…

Innovative Approach Enhances Outcomes in Metastatic NSCLC

A recent multicenter Phase II trial has demonstrated that combining chemoradiotherapy (CRT) with aggressive local consolidative therapy (LCT) can improve survival rates in patients with Stage IV non-small cell lung carcinoma (NSCLC) presenting with oligometastases.

Gut Microbiota Modulation: A Solution for Allergic Rhinitis

This study highlights the potential of probiotics as an adjunct treatment for allergic rhinitis, offering symptom relief and improving quality of life.

Kansas TB Outbreak Demands Immediate Medical Attention

Kansas is grappling with a significant tuberculosis (TB) outbreak, reporting 67 active cases, 60 in Wyandotte County and seven in Johnson County, and 79 confirmed latent TB infections, predominantly in Wyandotte County.

Brain Wave Patterns Linked to Pain Sensitivity

A recent cohort study has identified a novel cortical biomarker signature that accurately predicts individual pain sensitivity, offering promising implications for the diagnosis, prevention, and treatment of chronic pain.

Virtual Reality Subway Simulation Reveals the Impact of Sound on Balance Disorders

VR study reveals sound disrupts balance for those with inner ear disorders, aiding new clinical therapies.

New Model for Predicting Atherosclerotic Cardiovascular Disease in Individuals with Obesity

Discover AROSE, a new equation to better predict ASCVD risk in individuals with obesity, outperforming current models.

HIV Linked To Threefold Increased Coronary Risk

A recent prospective matched cohort study has revealed that individuals living with HIV (PWH) face a significantly higher risk of developing subclinical coronary atherosclerosis compared to the general population.

Immune Checkpoint Inhibitors: A Balancing Act

Risks of autoimmune conditions (ACs) in patients treated with immune checkpoint inhibitors (ICIs), a critical class of cancer immunotherapies, have been explored in a new epidemiological study.

Study Reveals Infection Trends in Patients With Ankylosing Spondylitis on Biologics

A study using the KOBIO registry reveals a 39 per 1,000 person-year infection rate in ankylosing spondylitis (AS) patients receiving biologics. Respiratory tract infections and herpes zoster were the most common, with age, diabetes, and kidney disease among key risk factors.